These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 29026882)
1. Efficient measurement and factorization of high-order drug interactions in Cokol M; Kuru N; Bicak E; Larkins-Ford J; Aldridge BB Sci Adv; 2017 Oct; 3(10):e1701881. PubMed ID: 29026882 [TBL] [Abstract][Full Text] [Related]
2. Efficient Measurement of Drug Interactions with DiaMOND (Diagonal Measurement of N-Way Drug Interactions). Van N; Degefu YN; Aldridge BB Methods Mol Biol; 2021; 2314():703-713. PubMed ID: 34235676 [TBL] [Abstract][Full Text] [Related]
3. Design of high-order antibiotic combinations against M. tuberculosis by ranking and exclusion. Yilancioglu K; Cokol M Sci Rep; 2019 Aug; 9(1):11876. PubMed ID: 31417151 [TBL] [Abstract][Full Text] [Related]
4. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method. Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948 [TBL] [Abstract][Full Text] [Related]
5. The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs. Bax HI; Bakker-Woudenberg IAJM; de Vogel CP; van der Meijden A; Verbon A; de Steenwinkel JEM Tuberculosis (Edinb); 2017 Jul; 105():80-85. PubMed ID: 28610791 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis. Rey-Jurado E; Tudó G; Martínez JA; González-Martín J Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid. López-Gavín A; Tudó G; Vergara A; Hurtado JC; Gonzalez-Martín J Int J Antimicrob Agents; 2015 Nov; 46(5):582-5. PubMed ID: 26421981 [TBL] [Abstract][Full Text] [Related]
8. Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo. Deshpande D; Srivastava S; Nuermberger E; Pasipanodya JG; Swaminathan S; Gumbo T Clin Infect Dis; 2016 Nov; 63(suppl 3):S88-S94. PubMed ID: 27742639 [TBL] [Abstract][Full Text] [Related]
9. Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations. Chen C; Wicha SG; Nordgren R; Simonsson USH AAPS J; 2018 Jun; 20(4):77. PubMed ID: 29931471 [TBL] [Abstract][Full Text] [Related]
14. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis. Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics. Bruhn DF; Scherman MS; Liu J; Scherbakov D; Meibohm B; Böttger EC; Lenaerts AJ; Lee RE Sci Rep; 2015 Sep; 5():13985. PubMed ID: 26365087 [TBL] [Abstract][Full Text] [Related]
17. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Khameneh B; Fazly Bazzaz BS; Amani A; Rostami J; Vahdati-Mashhadian N Microb Pathog; 2016 Apr; 93():83-7. PubMed ID: 26602814 [TBL] [Abstract][Full Text] [Related]
18. [Phage amplified biologically assay and its application in rapid detection of Mycobacterium tuberculosis]. Hu ZY Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):850-2. PubMed ID: 15730788 [No Abstract] [Full Text] [Related]